Cas:17236-59-8 thiophen-3-ol manufacturer & supplier

We serve Chemical Name:thiophen-3-ol CAS:17236-59-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

thiophen-3-ol

Chemical Name:thiophen-3-ol
CAS.NO:17236-59-8
Synonyms:3-S-hydroxythiophene;Thiophene-3-ol;4-thiophenol;3-hydroxythiophene;p-thiophenol
Molecular Formula:C4H4OS
Molecular Weight:100.13900
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:48.47000
Exact Mass:99.99830
LogP:1.45370

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-S-hydroxythiophene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-thiophenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-thiophenol Use and application,p-thiophenol technical grade,usp/ep/jp grade.


Related News: The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. 1-(3-chlorophenyl)-3-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)urea manufacturers Natural Biogenex, a 100 per cent subsidiary of Natural Capsules, is speeding up its efforts to manufacture active pharmaceutical ingredients (APIs) following the recent grant from Union government’s production linked incentive (PLI) scheme to offset the import dependence. sodium,1-amino-4-[2-methyl-5-[(4-methylphenyl)sulfonylamino]anilino]-9,10-dioxoanthracene-2-sulfonate suppliers (For more on Stevanato, see The Covid Vaccine Will Require Billions Of Tiny Glass Vials—And This Italian Billionaire Family Is Making Them.) sodium,1-amino-4-[2-methyl-5-[(4-methylphenyl)sulfonylamino]anilino]-9,10-dioxoanthracene-2-sulfonate vendor & factory The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago.,The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22.